Danaher (DHR) reported fiscal Q1 non-GAAP net earnings Tuesday of $1.88 per diluted share, down from $1.92 a year earlier.

Analysts polled by FactSet expected $1.63.

Sales for the fiscal quarter ended March 28 were $5.74 billion, down from $5.80 billion a year earlier.

Analysts surveyed by FactSet expected $5.57 billion.

For fiscal 2025, the life sciences company expects adjusted diluted EPS of $7.60 to $7.75.

Analysts polled by FactSet expect $7.66.

Shares of the company were up more than 2% in recent premarket activity.

Price: 190.00, Change: +5.04, Percent Change: +2.72